DNLI Chart
- 52-Week Range: $20.88 - $78.44
- Market Capitalization: $3.04B
- Short Percentage: 0%
- Target Price: $75.42
- Shares Outstanding: 122.95M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
DNLI released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Denali Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business HighlightsGlobeNewsWire | February 28th
- Denali Therapeutics Announces Appointment of Erik Harris to Board of DirectorsGlobeNewsWire | February 7th
- Denali Therapeutics Announces FDA Clinical Hold on DNL919 Investigational New Drug (IND) ApplicationGlobeNewsWire | January 13th
Company Info
Website: https://www.denalitherapeutics.com
Address: 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 380
Address: 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 380
$DNLI Keep up the pressure.
$DNLI See ya Monday
$DNLI Looking for this cup to breakout.
$DNLI added more calls on that drop
$DNLI buying this dip
$DNLI all’s I know is buy and hold… no expectations
$DNLI what a horse shit show!
$DNLI I gave in! Bought more 100 shares
$DNLI run it!
$DNLI HAVE A FANTASTIC WEEKEND FAM…